Segall Bryant & Hamill’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$668K	Hold	29,536	–	–	0.01%	540
2025 Q4	$764K	Sell	29,536 -147	-0.5%	-$3.5K	0.01%	524
2025 Q3	$765K	Sell	29,683 -82	-0.3%	-$2.01K	0.01%	521
2025 Q2	$711K	Sell	29,765 -2,120	-7%	-$53.4K	0.01%	525
2025 Q1	$792K	Sell	31,885 -176	-0.5%	-$4.21K	0.01%	522
2024 Q4	$604K	Hold	32,061	–	–	0.01%	546
2024 Q3	$483K	Buy	+32,061	New	+$548K	0.01%	545
2023 Q4	–	Sell	-137,925	Closed	-$4.23M	–	436
2023 Q3	$4.23M	Buy	137,925 +43,481	+46%	+$1.57M	0.05%	347
2023 Q2	$3.78M	Buy	94,444 +397	+0.4%	+$16.4K	0.04%	375
2023 Q1	$3.84M	Buy	94,047 +1,165	+1%	+$46.3K	0.04%	375
2022 Q4	$3.59M	Buy	92,882 +6,428	+7%	+$313K	0.04%	368
2022 Q3	$4.6M	Buy	86,454 +1,711	+2%	+$95.1K	0.05%	326
2022 Q2	$4.94M	Buy	84,743 +25,078	+42%	+$1.64M	0.06%	315
2022 Q1	$4.55M	Buy	59,665 +149	+0.3%	+$9.93K	0.04%	345
2021 Q4	$3.58M	Buy	59,516 +2,772	+5%	+$153K	0.03%	364
2021 Q3	$3.18M	Sell	56,744 -4,490	-7%	-$259K	0.03%	412
2021 Q2	$3.71M	Buy	61,234 +2,722	+5%	+$172K	0.04%	375
2021 Q1	$4.1M	Sell	58,512 -259	-0.4%	-$18.5K	0.04%	372
2020 Q4	$3.52M	Sell	58,771 -977	-2%	-$57.2K	0.04%	350
2020 Q3	$3.59M	Buy	59,748 +39,018	+188%	+$2.27M	0.05%	303
2020 Q2	$1.09M	Buy	20,730 +451	+2%	+$18.8K	0.02%	419
2020 Q1	$679K	Sell	20,279 -1,444	-7%	-$60K	0.01%	520
2019 Q4	$985K	Sell	21,723 -1,178	-5%	-$50K	0.02%	524
2019 Q3	$873K	Buy	22,901 +372	+2%	+$14.8K	0.01%	544
2019 Q2	$979K	Buy	22,529 +5,619	+33%	+$239K	0.01%	532
2019 Q1	$643K	Buy	16,910 +433	+3%	+$16.9K	0.01%	617
2018 Q4	$709K	Sell	16,477 -142	-0.9%	-$6.63K	0.01%	583
2018 Q3	$817K	Sell	16,619 -52	-0.3%	-$2.25K	0.01%	585
2018 Q2	$534K	Buy	+16,671	New	+$576K	0.01%	661